Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nephro Care India's Enterprise Value is ₹1,381.1 Mil.
Nephro Care India's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹18.9 Mil. Therefore, Nephro Care India's EV-to-EBIT ratio for today is 73.20.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Nephro Care India's Enterprise Value is ₹1,381.1 Mil.
Nephro Care India's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹48.5 Mil. Therefore, Nephro Care India's EV-to-EBITDA ratio for today is 28.47.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Nephro Care India's Enterprise Value is ₹1,381.1 Mil.
Nephro Care India's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹434.1 Mil. Therefore, Nephro Care India's EV-to-Revenue ratio for today is 3.18.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Nephro Care India (NSE:NEPHROCARE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹18.9 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹48.5 Mil.
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹434.1 Mil.
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephro Care India Enterprise Value Related Terms
Nephro Care India Enterprise Value Historical Data
* Premium members only.
The historical data trend for Nephro Care India's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEPHROCARE vs HCA, THC, EHC: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Nephro Care India's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Nephro Care India's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Nephro Care India's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ₹1,381.1 Mil mean?
Nephro Care India (NSE:NEPHROCARE) has a Enterprise Value of ₹1,381.1 Mil as of Sep. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nephro Care India and its competitors.
Is Nephro Care India's Enterprise Value too high?
Nephro Care India's current Enterprise Value is ₹1,381.1 Mil. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Enterprise Value compare to HCA and THC?
Nephro Care India's Enterprise Value of ₹1,381.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nephro Care India and its competitors. Nephro Care India's current Enterprise Value is ₹1,381.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Enterprise Value of ₹1,381.1 Mil. The current Enterprise Value is ₹1,381.1 Mil. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Enterprise Value is ₹1,381.1 Mil as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
